Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

AGN acquires (private) Bonti for $195M plus contingencies:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 720
Posts 108,618
Boards Moderated 21
Alias Born 09/05/02
160x600 placeholder
Amgen And Allergan's MVASI™ (bevacizumab-awwb) And KANJINTI™ (trastuzumab-anns) Now Available In The United States PR Newswire (US) - 7/18/2019 11:00:00 PM
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Oc... PR Newswire (US) - 7/17/2019 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/12/2019 5:16:53 PM
Drugmakers Rise After Trump Pricing Rule Is Blocked Dow Jones News - 7/9/2019 1:58:00 PM
Allergan Continues to Demonstrate Leadership in Migraine with 29 Presentations at the 2019 American Headache Society Annual M... PR Newswire (US) - 7/9/2019 7:41:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2019 4:46:59 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/2/2019 6:14:16 AM
U.S. Leads in Deals as World Lags -- WSJ Dow Jones News - 7/1/2019 3:02:00 AM
U.S. Deals Lead the Way as Rest of the World Lags Behind Dow Jones News - 6/30/2019 11:29:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2019 5:24:16 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2019 5:22:03 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2019 5:17:16 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2019 5:15:34 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/27/2019 4:39:52 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/27/2019 6:31:48 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/26/2019 4:50:53 PM
Facing Challenges, Firms Seek Deals -- WSJ Dow Jones News - 6/26/2019 3:02:00 AM
Drugmakers Strike $63 Billion Deal -- WSJ Dow Jones News - 6/26/2019 3:02:00 AM
WeissLaw LLP Investigates Allergan Plc PR Newswire (US) - 6/25/2019 6:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:20:18 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/25/2019 5:18:31 PM
S&P Puts AbbVie on Watch Negative After Allergan Deal Dow Jones News - 6/25/2019 2:37:00 PM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--6th Update Dow Jones News - 6/25/2019 11:44:00 AM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--5th Update Dow Jones News - 6/25/2019 10:53:00 AM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--4th Update Dow Jones News - 6/25/2019 10:06:00 AM
DewDiligence Member Level  Friday, 09/14/18 10:12:43 AM
Re: None
Post # of 194 
AGN acquires (private) Bonti for $195M plus contingencies:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143556549

Bonti’s product candidate is a type-E botulinum toxin, which is an altogether different animal from type-A botulinum toxins such as Botox and RVNC’s RT002.

I previously commented on Bonti in #msg-137948777 and #msg-137955390.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist